Drug Makers File With European Medicines Agency For Regulatory Approval Of Investigational Ebola Vaccine; WHO Notes Fluctuating Pattern Of Disease Transmission In DRC Outbreak
CIDRAP News: European regulators consider 2nd Ebola vaccine
“Bavarian Nordic [Thursday] announced that it and its partner Janssen Pharmaceuticals, part of Johnson & Johnson, have submitted an application to the European Medicines Agency (EMA) for approval of their investigational two-dose Ebola vaccine regimen. The news comes as one new Ebola case was reported [Thursday] in the Democratic Republic of the Congo (DRC) outbreak, part of a fluctuating pattern that the World Health Organization (WHO) noted [Thursday] in its weekly snapshot of the event…” (Schnirring, 11/7).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.